7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with levodopa in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Misu, Y; Okumura, F; Sato, K; Ueda, H | 1 |
Andersen, SL; Dumont, NL; Teicher, MH | 1 |
Maj, J; Rogóz, Z; Skuza, G | 1 |
Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P | 1 |
Choi, JK; Iris Chen, YC; Isacson, O; Jenkins, BG; Sánchez-Pernaute, R | 1 |
5 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and levodopa
Article | Year |
---|---|
L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats.
Topics: Acetylcholine; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Drug Synergism; Ergolines; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Quinpirole; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 1995 |
Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT.
Topics: Age Factors; Animals; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Levodopa; Nucleus Accumbens; Prefrontal Cortex; Quinpirole; Rats; Rats, Sprague-Dawley; Salicylamides; Tetrahydronaphthalenes | 1997 |
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Haloperidol; Hyperkinesis; Levodopa; Locomotion; Male; Naphthalenes; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Tetrahydronaphthalenes | 1999 |
Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Antiparkinson Agents; Benzazepines; Binding, Competitive; Corpus Striatum; Denervation; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Enkephalins; Excitatory Amino Acid Antagonists; Gene Expression; Levodopa; Male; Neural Pathways; Neurons; Opioid Peptides; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substantia Nigra; Sympatholytics; Tachykinins; Tetrahydronaphthalenes; Tritium; Ventral Tegmental Area | 2000 |
In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.
Topics: Animals; Brain; Cerebrovascular Circulation; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Macaca fascicularis; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2007 |